首页> 美国卫生研究院文献>Oncology Letters >Polymorphisms of mismatch repair gene hMLH1 and hMSH2 and risk of gastric cancer in a Chinese population
【2h】

Polymorphisms of mismatch repair gene hMLH1 and hMSH2 and risk of gastric cancer in a Chinese population

机译:错配修复基因hMLH1和hMSH2的多态性与中国人群胃癌的风险

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The purpose of this study was to determine the genotype and allele frequencies of hMLH1 (-93G>A and I219V) and hMSH2 (-118T>C and IVS12-6T>C) polymorphisms in patients with gastric carcinoma and normal controls, and to evaluate the association between these polymorphisms and the risk of gastric cancer in a hospital-based Chinese population. Genomic DNA was extracted from peripheral blood lymphocytes. A TaqMan assay was used to determine the genotype and allele frequencies of hMLH1 and hMSH2 polymorphisms in data obtained from 554 gastric cancer cases and 592 controls. Unconditional logistic regression was used to assess the association between the four single nucleotide polymorphisms (SNPs) and gastric carcinoma risk. No evidence of an association among any of the four polymorphisms and the risk of gastric cancer was observed. However, when gastric cancer patients were further stratified by age, gender, smoking status, alcohol use and clinicopathological characteristics, and compared with the control populations, the combined variant genotype hMSH2 -118T>C (TC+CC) was not only associated with an increased risk of gastric cancer in subgroups of younger subjects [ages ≤63years; adjusted odds ratio (OR)=1.51, 95% confidence interval (CI), 1.05–2.16], but also with diffuse tumors (adjusted OR=1.41, 95% CI, 1.01–1.96). These data indicate that the polymorphisms of -93G>A, I219V and IVS12-6T>C are not associated with the risk of gastric cancer. However, hMSH2-118T>C combined with variant genotypes (TC+CC) may confer a potential risk of gastric cancer in the Chinese population.
机译:这项研究的目的是确定胃癌和正常对照中hMLH1(-93G> A和I219V)和hMSH2(-118T> C和IVS12-6T> C)多态性的基因型和等位基因频率,并评估这些多态性与以医院为基础的中国人群胃癌风险之间的关系。从外周血淋巴细胞中提取基因组DNA。 TaqMan分析用于确定554例胃癌病例和592例对照的hMLH1和hMSH2多态性的基因型和等位基因频率。使用无条件逻辑回归来评估四种单核苷酸多态性(SNP)与胃癌风险之间的关联。没有证据表明这四个多态性与胃癌的风险之间存在关联。但是,当进一步根据年龄,性别,吸烟状况,饮酒和临床病理特征对胃癌患者进行分层,并与对照组相比时,组合的基因型hMSH2 -118T> C(TC + CC)不仅与年轻受试者亚组[≤63岁;调整后的优势比(OR)= 1.51,置信区间(CI)为95%,1.05-2.16],但对于弥漫性肿瘤也是如此(调整后的OR = 1.41,95%CI,1.01-1.96)。这些数据表明-93G> A,I219V和IVS12-6T> C的多态性与患胃癌的风险无关。然而,hMSH2-118T> C结合变异基因型(TC + CC)可能会给中国人群带来胃癌的潜在风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号